Pesquisa | BVS Doenças Infecciosas e Parasitárias

1.

Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT).

Saiag, P; Gutzmer, R; Ascierto, P A; Maio, M; Grob, J-J; Murawa, P; Dreno, B; Ross, M; Weber, J; Hauschild, A; Rutkowski, P; Testori, A; Levchenko, E; Enk, A; Misery, L; Vanden Abeele, C; Vojtek, I; Peeters, O; Brichard, V G; Therasse, P.

Ann Oncol ; 27(10): 1947-53, 2016 10.

Artigo em Inglês | MEDLINE | ID: mdl-27502712

2.

A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene.

Guilloux, Y; Lucas, S; Brichard, V G; Van Pel, A; Viret, C; De Plaen, E; Brasseur, F; Lethé, B; Jotereau, F; Boon, T.

J Exp Med ; 183(3): 1173-83, 1996 Mar 01.

Artigo em Inglês | MEDLINE | ID: mdl-8642259

3.

New tumor antigens recognized by T cells.

Van den Eynde, B; Brichard, V G.

Curr Opin Immunol ; 7(5): 674-81, 1995 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-8573311

4.

Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study.

Gutzmer, R; Rivoltini, L; Levchenko, E; Testori, A; Utikal, J; Ascierto, P A; Demidov, L; Grob, J J; Ridolfi, R; Schadendorf, D; Queirolo, P; Santoro, A; Loquai, C; Dreno, B; Hauschild, A; Schultz, E; Lesimple, T P; Vanhoutte, N; Salaun, B; Gillet, M; Jarnjak, S; De Sousa Alves, P M; Louahed, J; Brichard, V G; Lehmann, F F.

ESMO Open ; 1(4): e000068, 2016.

Artigo em Inglês | MEDLINE | ID: mdl-27843625

5.

Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815.

Brichard, V G; Warnier, G; Van Pel, A; Morlighem, G; Lucas, S; Boon, T.

Eur J Immunol ; 25(3): 664-71, 1995 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-7705394

6.

A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes.

Brichard, V G; Herman, J; Van Pel, A; Wildmann, C; Gaugler, B; Wölfel, T; Boon, T; Lethé, B.

Eur J Immunol ; 26(1): 224-30, 1996 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-8566071

7.

A tyrosinase peptide presented by HLA-B35 is recognized on a human melanoma by autologous cytotoxic T lymphocytes.

Morel, S; Ooms, A; Van Pel, A; Wölfel, T; Brichard, V G; van der Bruggen, P; Van den Eynde, B J; Degiovanni, G.

Int J Cancer ; 83(6): 755-9, 1999 Dec 10.

Artigo em Inglês | MEDLINE | ID: mdl-10597191

8.

Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus.

Yee, C; Gilbert, M J; Riddell, S R; Brichard, V G; Fefer, A; Thompson, J A; Boon, T; Greenberg, P D.

J Immunol ; 157(9): 4079-86, 1996 Nov 01.

Artigo em Inglês | MEDLINE | ID: mdl-8892642

9.

Genes coding for tumor antigens recognized by cytolytic T lymphocytes.

Van Pel, A; van der Bruggen, P; Coulie, P G; Brichard, V G; Lethé, B; van den Eynde, B; Uyttenhove, C; Renauld, J C; Boon, T.

Immunol Rev ; 145: 229-50, 1995 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-7590828

BVS Doenças Infecciosas e Parasitárias

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar: